rs376341411
Variant summary
Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PM1PP3_Moderate
The NM_006005.3(WFS1):c.1984T>C(p.Ser662Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000186 in 1,613,406 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. S662S) has been classified as Likely benign.
Frequency
Consequence
NM_006005.3 missense
Scores
Clinical Significance
Conservation
Publications
- Wolfram-like syndromeInheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, Ambry Genetics, ClinGen, Orphanet
- Wolfram syndromeInheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- autosomal dominant nonsyndromic hearing loss 6Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- cataract 41Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- Wolfram syndrome 1Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- autosomal dominant nonsyndromic hearing lossInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- early-onset nuclear cataractInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- type 2 diabetes mellitusInheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
WFS1 | NM_006005.3 | c.1984T>C | p.Ser662Pro | missense_variant | Exon 8 of 8 | ENST00000226760.5 | NP_005996.2 | |
WFS1 | NM_001145853.1 | c.1984T>C | p.Ser662Pro | missense_variant | Exon 8 of 8 | NP_001139325.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152198Hom.: 0 Cov.: 34 show subpopulations
GnomAD2 exomes AF: 0.0000239 AC: 6AN: 250930 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.00000890 AC: 13AN: 1461208Hom.: 0 Cov.: 99 AF XY: 0.00000963 AC XY: 7AN XY: 726950 show subpopulations
GnomAD4 genome AF: 0.000112 AC: 17AN: 152198Hom.: 0 Cov.: 34 AF XY: 0.0000673 AC XY: 5AN XY: 74342 show subpopulations
ClinVar
Submissions by phenotype
not provided Uncertain:2
Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt WFS1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. ClinVar contains an entry for this variant (Variation ID: 166600). This variant has not been reported in the literature in individuals affected with WFS1-related conditions. This variant is present in population databases (rs376341411, gnomAD 0.04%). This sequence change replaces serine, which is neutral and polar, with proline, which is neutral and non-polar, at codon 662 of the WFS1 protein (p.Ser662Pro). -
Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 26435059) -
not specified Uncertain:1
The Ser662Pro variant in WFS1 has not been reported in individuals with hearing loss, but has been identified in 0.05% (2/4406) of African American chromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS/). Compu tational analyses (biochemical amino acid properties, conservation, AlignGVGD, P olyPhen2, and SIFT) suggest that the Ser662Pro variant may impact the protein, t hough this information is not predictive enough to determine pathogenicity. In s ummary, additional data is needed to determine the clinical significance of this variant. -
Type 2 diabetes mellitus;C1833021:Autosomal dominant nonsyndromic hearing loss 6;C3280358:Wolfram-like syndrome;C3805412:Cataract 41;C4551693:Wolfram syndrome 1 Uncertain:1
- -
Wolfram syndrome 1 Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at